Jul 10, 2026 11:23AM
Jul 10, 2026 11:23AM
Jun 22, 2026 04:30PM
Jun 22, 2026 04:30PM
Jun 9, 2026 09:44AM
Jun 6, 2026 06:03PM
Jun 1, 2026 02:53AM Pfizer's BRAFTOVI regimen shows improved survival in colorectal cancer
May 31, 2026 08:00AM
May 18, 2026 08:00AM
May 12, 2026 05:37AM
May 11, 2026 08:30AM
May 5, 2026 06:45AM
Apr 20, 2026 06:45AM
Apr 20, 2026 06:45AM U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
Apr 8, 2026 06:44PM
Mar 20, 2026 04:30PM
Mar 20, 2026 04:30PM
Feb 27, 2026 10:04AM
Feb 27, 2026 10:00AM
Feb 24, 2026 02:30PM
Feb 24, 2026 02:29PM U.S. FDA Grants Full Approval to Pfizer’s BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer
Feb 17, 2026 08:00AM
Feb 17, 2026 06:47AM
Feb 17, 2026 06:45AM
Feb 3, 2026 06:52AM
Feb 3, 2026 06:45AM
Feb 3, 2026 06:40AM
Feb 3, 2026 06:40AM Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial
Jan 23, 2026 06:29AM
Jan 12, 2026 04:09AM
Jan 10, 2026 10:00AM
Jan 8, 2026 04:30PM
Jan 8, 2026 04:30PM
Dec 17, 2025 08:03AM
Dec 17, 2025 06:46AM PADCEV-Keytruda combo shows survival benefit in bladder cancer trial
Dec 17, 2025 06:45AM
Dec 16, 2025 10:34AM
Dec 16, 2025 06:54AM
Dec 16, 2025 06:45AM
Dec 16, 2025 06:45AM
Dec 9, 2025 06:43AM
Nov 21, 2025 01:24PM FDA approves PADCEV plus Keytruda for bladder cancer patients
Nov 21, 2025 01:24PM
Nov 13, 2025 11:26AM
Nov 13, 2025 11:26AM
Nov 8, 2025 01:55AM
Nov 6, 2025 08:48AM
Nov 5, 2025 05:13PM
Nov 5, 2025 05:08PM Pfizer Responds to Delaware Chancery Court Ruling
Nov 4, 2025 09:20AM

1,169,797 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All